Markets.com Logo

IVACC

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.028$
  • Previous Close
    1.0719$
  • 52 Week Change
    3.69$
  • Day Range
    -0.04$
  • 52 Week High/Low
    0.751$ - 4.44$
  • Dividend Per Share
    --
  • Market cap
    348 M$
  • EPS
    -0.08
  • Beta
    0.525
  • Volume
    --

About

IVACC.ST represents the shares of Immunicum AB, a Swedish biopharmaceutical company listed on the Nasdaq First North Growth Market in Stockholm. Immunicum is focused on developing novel, cell-based immunotherapies for the treatment of solid tumors. The company's lead product candidate is ilixadencel, an off-the-shelf cell-based immunotherapy designed to activate the patient's own immune system to fight cancer. Investors can track the performance of Immunicum AB through the IVACC.ST ticker symbol on the Stockholm stock exchange.

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist

Emma Rose|--

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Emma Rose|--

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

Sophia Claire|--

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Sophia Claire|--

Global Debt Crisis Deepens Amidst Iran Conflict and Fiscal Fragility

Ava Grace|--

Apple's Strategic Pivot: MacBook Neo, Supply Chain Tactics, and Foldable Phone Hurdles

Emma Rose|--

Factors

Company Performance: Positive earnings reports, successful clinical trials, and new product approvals can increase investor confidence and drive up the stock price.

Industry Trends: Positive developments in the vaccine industry, such as increased government funding or a rise in infectious disease outbreaks, can positively impact IVACC.ST.

Market Sentiment: Overall investor optimism or pessimism regarding the stock market and biotechnology sector can influence the demand for IVACC.ST shares.

Regulatory Environment: Changes in regulations related to drug approvals, pricing, or intellectual property can impact the company's profitability and stock price.

Competition: The emergence of new competitors or the success of existing rivals can affect IVACC.ST's market share and investor perception.

Macroeconomic Factors: Economic growth, interest rates, and inflation can all influence investor decisions and the overall stock market, including IVACC.ST.

Global Health Crises: Pandemics or epidemics can create significant demand for vaccines, potentially boosting IVACC.ST's revenue and stock price.

Investor Perception of Risk: The inherent risks associated with biotechnology companies, such as clinical trial failures or regulatory setbacks, can affect investor willingness to invest in IVACC.ST.

News and Events: Major announcements, such as partnerships, acquisitions, or product recalls, can cause fluctuations in the stock price.

Technological Advancements: Breakthroughs in vaccine technology or manufacturing processes can give IVACC.ST a competitive advantage and attract investors.

People Also Watch

Latest news

Close Coordination Between Israel and US on Iran Nuclear Talks Highlighted

Noah Lee|--

US-Iran Talks Show Progress Towards Ceasefire Framework Agreement

Liam James|--

Federal Reserve Independence Under Historic Test: Navigating Democratic Legitimacy and Political Pressure

Liam James|--

Latest Education Articles

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Julian Parker|--
Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Frances Wang|--
Recommended Topics